Article
RNA polymerase (rpoB) mutants selected for increased resistance to gyrase inhibitors in Salmonella typhimurium.
Molecular & general genetics : MGG - 25 Jun 1995
Blanc-Potard A B, Gari E, Spirito F, Figueroa-Bossi N, Bossi L
Abstract excerpt
Some rifampicin-resistance (RifR) mutations make bacteria slightly resistant to the gyrase inhibitors novobiocin (Nov) and nalidixic acid (Nal). This suggested that it might be possible to isolate rpoB mutants using either drug for positive selection. In an initial test, we confirmed the presence...
Topics
- DNA Gyrase
- DNA Replication
- DNA Topoisomerases, Type II
- DNA-Directed RNA Polymerases
- Drug Resistance, Microbial
- Histidine
- Kinetics
- Lac Operon
- Mutation
- Nalidixic Acid
- Novobiocin
- RNA, Transfer, His
